BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31430054)

  • 1. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking.
    Bidan N; Bailleul-Dubois J; Duval J; Winter M; Denoulet M; Hannebicque K; El-Sayed IY; Ginestier C; Forissier V; Charafe-Jauffret E; Macario M; Matsunaga YT; Meignan S; Anquez F; Julien S; Bonnefond A; Derhourhi M; Le Bourhis X; Lagadec C
    Proteomics; 2019 Nov; 19(21-22):e1800454. PubMed ID: 31430054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
    Okamoto A; Funakoshi Y; Oe M; Takai R; Suto H; Nagatani Y; Nishimura M; Imamura Y; Kunihisa T; Kiyota N; Miki K; Ohe K; Tanino H; Minami H
    Anticancer Res; 2022 Mar; 42(3):1199-1205. PubMed ID: 35220209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
    Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
    Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
    Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
    Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
    Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
    Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.
    Shimamura M; Nagayama Y; Matsuse M; Yamashita S; Mitsutake N
    Endocr J; 2014; 61(5):481-90. PubMed ID: 24531915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
    Tan S; Yamashita A; Gao SJ; Kurisawa M
    Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
    Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
    Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
    Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
    Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
    Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
    Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.